Cn /En

News Center

——

Company news

Industry news

Features and Advantages of the Immunoculture Killing Model Platform of InnoModels Biotechnology

Author:

InnoModels

Release time:

2024-08-02

With significant achievements in the field of cancer therapy and immunotherapy, the newly launched Immunoco-culture Killing Model Platform of InnoModels Biotechnology provides researchers with an experimental platform that is closer to the in vivo physiological context, with unique features and significant advantages. This article will introduce the main features and advantages of the platform in detail.
Features:
1. Highly simulates the in vivo environment:
The platform constructs a more realistic 3D tissue structure through precise cell culture technology, simulating the complex interactions between immune cells and tumor cells in vivo. This simulation not only includes direct cell-to-cell interactions, but also involves the simulation of the complex immune microenvironment, making the experimental results more physiologically relevant.
2. Introduction of multiple cell types:
Unlike traditional immune models, the immune co-culture killing model of InnoModels Biotechnology is able to simultaneously introduce multiple immune cell types, such as natural killer cells (NK cells), T cells, etc., so as to simulate a more complex immune response process. This introduction of multiple cell types makes the experimental results more biologically meaningful and can reflect the interaction between immune cells and tumor cells more comprehensively.
3. Real-time observation and imaging analysis:
Utilizing advanced microscopy techniques and imaging analysis, the platform enables real-time observation at the cellular level. This visualization feature enables researchers to intuitively observe the killing process of immune cells and thus gain a deeper understanding of the mechanisms of immunotherapy.
4. High-throughput automation technology:
In order to improve experimental efficiency, the platform adopts high-throughput automation technology, which is capable of processing multiple samples at the same time and realizing large-scale data collection and analysis. This technical tool enables researchers to assess the effects of different treatment programs more quickly and comprehensively.
5. Diversified experimental service system:
The platform supports the combination experiments of many types of tumor cells and immune cells, including tumor cell lines, primary tumor cells and genetically engineered cell lines. Meanwhile, for effector cells, the platform also supports commercially sourced PBMC (peripheral blood mononuclear cells) as well as clinical patient-sourced PBMC, providing researchers with a rich choice of space.

Advantages:
1. Accurate killing assessment:
By separating effector cells (immune cells) from target cells (tumor cells), the platform enables precise assessment of killing. Using CSFE and CD45 markers, the platform is able to distinguish between effector and target cells and verify target cell killing using flow cytometry, thus minimizing the impact of immune cell proliferation and apoptosis on test results.
2. Comprehensive immune response analysis:
The platform not only detects specific activation of immune cells, but also identifies non-specific activation, such as activation of T cells by CD3, CD28 and IL-2. This capability allows researchers to distinguish between specific and non-specific immune responses, providing a comprehensive view of immune cell activity.
3. Enhanced research relevance:
By simulating immune-mediated killing responses in vivo, the platform provides a more physiologically relevant model for studying immune responses to tumors. Such models not only help to more accurately predict the effects of therapeutic agents in vivo, but also provide critical support for the development and evaluation of immunotherapy.
4. Broad application areas:
The platform has a wide range of applications in cancer treatment research, including immunotherapy development, drug screening, immunology research, and personalized medicine. Especially in the field of personalized medicine, tailoring the treatment based on the immune response of individual patients can significantly improve the therapeutic effect.
5. Flexible experiment design:
The platform is highly customizable, allowing personalized experimental protocols to be tailored to the specific needs of the researcher. Whether it is cell type, drug treatment or experimental time and other aspects, the platform can meet the diverse needs of researchers, providing powerful technical support for biomedical research.
Conclusion:
With its highly simulated in vivo environment, introduction of multiple cell types, real-time observation and imaging analysis, high-throughput automation technology, and diversified experimental service system, InnoModels' bio-immunity co-culture killing model platform has demonstrated significant advantages in cancer therapy and immunotherapy research. In the future, with the continuous development of the biomedical field, the platform will play a greater role in promoting the progress of cancer treatment and immunotherapy research, bringing more hope and possibilities to patients.

Introduction to the Gouty Arthritis (GA) model of InnoModels Biotechnology

Analysis of the Features ofInnoModels’ADCC Platform

Introduction to the Gouty Arthritis (GA) model of InnoModels Biotechnology

Analysis of the Features ofInnoModels’ADCC Platform

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License